Plant Comparison
Bitter Melon vs Tansy
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Bitter Melon and Tansy: they share 5 indicated uses (arthritis / joint pain, bloating, indigestion, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Bitter Melon | Tansy | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 1/10 | Stronger for Bitter Melon |
| Bloating | 1/10 | 1/10 | Comparable evidence |
| Indigestion | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Now regarded as the main antidiabetic principles.
A mixture of two sterol glucosides, historically credited with the hypoglycaemic effect.
An insulin-like polypeptide of the fruit and seed.
A pyrimidine glycoside that can trigger favism in G6PD-deficient people.
Thujone is the neurotoxic, safety-limiting constituent responsible for tansy's real internal-use toxicity.
Contribute to the plant's bitter taste and antimicrobial activity.
Pharmacological Actions
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Traditional & Indicated Uses
inferred from bitter-tonic action
inferred from anti-inflammatory action
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Avoid in pregnancy: bitter melon can stimulate the uterus and has been associated with miscarriage; also avoid during breastfeeding.
Strong blood-sugar-lowering action: used with insulin or other diabetes medicines it can cause hypoglycaemia - monitor blood glucose and seek medical advice.
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid the seeds, which contain vicine and can cause favism (haemolytic anaemia). Excessive intake may cause abdominal pain and diarrhoea.
CAUTION: Tansy is considered toxic in medicinal doses and is NOT recommended for internal use. Thujone can cause convulsions, liver and kidney damage. Contraindicated in pregnancy (uterotonic and abortifacient). External use (as insect repellent) is generally safe. For information and historical reference only — do not use internally.
Duke (2002) rates tansy as ++ but emphasizes important safety concerns. The plant contains thujone (a neurotoxic ketone) and camphor, making it potentially toxic with internal use. Documented activities include emmenagogue, abortifacient (score 1), and insecticide. Duke strongly cautions against internal use except under professional supervision, noting that historical cases of tansy poisoning have resulted in convulsions and death. Topical use as an insect repellent is safer but should still avoid prolonged skin contact due to the essential oil's sensitizing potential. Strictly contraindicated in pregnancy (Duke, 2002).
External Ids
Botanical Description
Climbing or trailing annual vine (Cucurbitaceae) that climbs by simple tendrils, typically 2-5 m long. Leaves are alternate, long-stalked and palmately lobed with 5-7 deep, toothed lobes. Flowers are small, yellow and five-petalled, male and female flowers separate on the same plant. The fruit is an oblong, warty-skinned gourd that ripens from green to orange-yellow and splits open to reveal seeds coated in a bright red aril; the unripe green fruit is the part used medicinally and as food.
Aromatic perennial herb (Asteraceae), 50-120 cm tall, with erect, reddish, ridged stems. Leaves are finely divided, fern-like and strongly camphor-scented. Flat-topped clusters of small, yellow, button-like flower heads lack ray florets (petals).[11]
Habitat
Likely native to tropical Asia (possibly the Indian subcontinent), now widely cultivated across tropical and subtropical Asia, Africa, the Caribbean and increasingly the Americas as a vegetable and medicinal crop; needs warmth, full sun and a trellis or support to climb.[11]
Native to Europe and temperate Asia, widely naturalised elsewhere; grows on roadsides, waste ground, riverbanks and disturbed grassland.[11]
Harvesting
The fruit is harvested unripe, while still green and firm, before it yellows and splits, for use as a vegetable and in traditional antidiabetic preparations; leaves are also traditionally gathered.[11]
Flowering aerial parts are cut in summer, when in full flower, and dried for external/historical use; given this plant's real toxicity (thujone content) at internal doses, this record does not recommend or describe internal harvesting for medicinal consumption.[11]
Traditional Uses
Bitter melon has a long history in Asian, African and Caribbean traditional medicine as a bitter digestive tonic and mild laxative, and most notably as a remedy for diabetes and its complications; this traditional antidiabetic use is now the most scientifically supported of its properties, with numerous studies on its blood-glucose- and lipid-lowering effects.[4, 11]
Tansy has a long European history as a strewing herb, insect repellent and, historically, an internal vermifuge and emmenagogue, but its thujone and camphor content make internal medicinal use unsafe by modern standards. Today it is used, with caution, mainly as an external insect repellent; the traditional internal uses are recorded here for historical reference only, not as a recommendation.[11]
Preparations
Dosage
Clinical trials studying bitter melon for blood-sugar support have used standardised fruit extract or juice preparations taken daily over several weeks; dosing varies by product. Because it can lower blood glucose, monitor levels closely if combining with diabetes medication. Educational reference only, not a prescription.
Tansy is NOT recommended for internal use at any dose given its thujone content and documented toxicity (convulsions, liver/kidney damage) - internal use recorded here is for historical reference only. External use (e.g. as an insect repellent) should avoid prolonged skin contact. Educational reference only, not a prescription; strictly avoid in pregnancy.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Kim, S.K., Jung, J., Jung, J.H., Yoon, N. and others (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800 Meta-analysis / review
https://doi.org/10.2174/1389203719666180622095800 - Raina, K., Kumar, D. and Agarwal, R (2016) 'Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy', Seminars in Cancer Biology, 40-41, pp. 116-129. doi:10.1016/j.semcancer.2016.07.002 Meta-analysis / review
https://doi.org/10.1016/j.semcancer.2016.07.002 - Basch, E., Gabardi, S. and Ulbricht, C (2003) 'Bitter melon (Momordica charantia): a review of efficacy and safety', American Journal of Health-System Pharmacy, 60(4), pp. 356-359. doi:10.1093/ajhp/60.4.356 Meta-analysis / review
https://doi.org/10.1093/ajhp/60.4.356 - Bora, A.F.M., Kouame, K.J.E., Li, X., Liu, L. and others (2023) 'New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review', International Journal of Biological Macromolecules, 231, pp. 123173. doi:10.1016/j.ijbiomac.2023.123173 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2023.123173 - Soo May, L., Sanip, Z., Ahmed Shokri, A., Abdul Kadir, A. and others (2018) 'The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial', Complementary Therapies in Clinical Practice, 32, pp. 181-186. doi:10.1016/j.ctcp.2018.06.012 Randomized trial
https://doi.org/10.1016/j.ctcp.2018.06.012 - Elekofehinti, O.O., Ariyo, E.O., Akinjiyan, M.O., Olayeriju, O.S. and others (2018) 'Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies', Pathophysiology, 25(4), pp. 327-333. doi:10.1016/j.pathophys.2018.05.003 Preclinical
https://doi.org/10.1016/j.pathophys.2018.05.003 - Leung, L., Birtwhistle, R., Kotecha, J., Hannah, S. and others (2009) 'Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review', British Journal of Nutrition, 102(12), pp. 1703-1708. doi:10.1017/S0007114509992054 Meta-analysis / review
https://doi.org/10.1017/S0007114509992054 - Krawinkel, M.B. and Keding, G.B (2006) 'Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia', Nutrition Reviews, 64(7 Pt 1), pp. 331-337. doi:10.1301/nr.2006.jul.331-337 Meta-analysis / review
https://doi.org/10.1301/nr.2006.jul.331-337 - Fang, E.F. and Ng, T.B (2011) 'Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties', Current Molecular Medicine, 11(5), pp. 417-436. doi:10.2174/156652411795976583 Meta-analysis / review
https://doi.org/10.2174/156652411795976583 - Cicek, S.S (2022) 'Momordica charantia L. - Diabetes-Related Bioactivities, Quality Control, and Safety Considerations', Frontiers in Pharmacology. doi:10.3389/fphar.2022.904643 Traditional / reference
https://doi.org/10.3389/fphar.2022.904643 - WebMD (n.d.) 'Bitter Melon: Overview, Uses, Side Effects, Precautions, Interactions'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon - Yedjou, C.G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L. and Tchounwou, P.B (2023) 'The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins', International Journal of Molecular Sciences. doi:10.3390/ijms24109085 Randomized trial
https://doi.org/10.3390/ijms24109085 - Kim, S.K., Jung, J., Jung, J.H., Yoon, N., Kang, S.S., Roh, G.S. and Hahm, J.R (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126
- Kowalonek, J., Stachowiak, N., Bolczak, K. and Richert, A (2023) 'Physicochemical and Antibacterial Properties of Alginate Films Containing Tansy (Tanacetum vulgare L.) Essential Oil', Polymers, 15(2), pp. 260. doi:10.3390/polym15020260 Preclinical
https://doi.org/10.3390/polym15020260 - Ak, G., Gevrenova, R., Sinan, K.I., Zengin, G. and others (2021) 'Tanacetum vulgare L. (Tansy) as an effective bioresource with promising pharmacological effects from natural arsenal', Food and Chemical Toxicology, 153, pp. 112268. doi:10.1016/j.fct.2021.112268 Preclinical
https://doi.org/10.1016/j.fct.2021.112268 - Paderin, N.M., Saveliev, Y.N. and Popov, S.V (2020) 'The effect of pectin of tansy, Tanacetum vulgare L., on anxiety and overeating food rich in fats and sugars in mice in modelling binge eating', Voprosy Pitaniia, 89(6), pp. 14-22. doi:10.24411/0042-8833-2020-10074 Preclinical
https://doi.org/10.24411/0042-8833-2020-10074 - Babich, O., Larina, V., Krol, O., Ulrikh, E. and others (2023) 'In Vitro Study of Biological Activity of Tanacetum vulgare Extracts', Pharmaceutics, 15(2), pp. 616. doi:10.3390/pharmaceutics15020616 Preclinical
https://doi.org/10.3390/pharmaceutics15020616 - Puk, K. and Guz, L (2021) 'Parasiticidal effects of Tanacetum vulgare extract against Ichthyophthirius multifiliis', Polish Journal of Veterinary Sciences, 24(1), pp. 159-161. doi:10.24425/pjvs.2021.136805 Preclinical
https://doi.org/10.24425/pjvs.2021.136805 - Roman, H., Niculescu, A.G., Lazar, V. and Mitache, M.M (2023) 'Antibacterial Efficiency of Tanacetum vulgare Essential Oil against ESKAPE Pathogens and Synergisms with Antibiotics', Antibiotics, 12(11), pp. 1635. doi:10.3390/antibiotics12111635 Preclinical
https://doi.org/10.3390/antibiotics12111635 - Sukele, R., Lauberte, L., Kovalcuka, L., Logviss, K. and others (2023) 'Chemical Profiling and Antioxidant Activity of Tanacetum vulgare L. Wild-Growing in Latvia', Plants, 12(10), pp. 1968. doi:10.3390/plants12101968 Preclinical
https://doi.org/10.3390/plants12101968 - Korpinen, R.I., Valimaa, A.L., Liimatainen, J. and Kunnas, S (2021) 'Essential Oils and Supercritical CO2 Extracts of Arctic Angelica, Marsh Labrador Tea and Common Tansy (Tanacetum vulgare)-Chemical Compositions and Antimicrobial Activities', Molecules, 26(23), pp. 7121. doi:10.3390/molecules26237121 Preclinical
https://doi.org/10.3390/molecules26237121 - Jovanovic, M. and Poljacki, M (2003) 'Compositae dermatitis', Medicinski Pregled, 56(1-2), pp. 43-49. doi:10.2298/mpns0302043j Meta-analysis / review
https://doi.org/10.2298/mpns0302043j - Rohloff, J., Mordal, R. and Dragland, S (2004) 'Chemotypical variation of tansy (Tanacetum vulgare L.) from 40 different locations in Norway', Journal of Agricultural and Food Chemistry, 52(6), pp. 1742-1748. doi:10.1021/jf0352430 Preclinical
https://doi.org/10.1021/jf0352430 - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Kivilaan, A. and Bandurski, R.S (1981) 'The 1879 Beal seed viability experiment', 68(9), pp. 1290--1292. Traditional / reference
https://scholar.google.com/scholar?q=The%201879%20Beal%20seed%20viability%20experiment - Orav, A., Raal, A. and Arak, E (2006) 'Essential oil composition of Tanacetum vulgare L', 20(12), pp. 1129--1142. Traditional / reference
https://scholar.google.com/scholar?q=Essential%20oil%20composition%20of%20Tanacetum%20vulgare%20L - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Washington State Noxious Weed Control Board 'Tansy Ragwort (Senecio jacobaea)'. Available at: https://www.nwcb.wa.gov/weeds/tansy-ragwort Traditional / reference
https://www.nwcb.wa.gov/weeds/tansy-ragwort - Schneider, J. and Tsegaye, Y. and W/Tensae, M. and G/Selassie, S. and Haile, T. and Bane, A. and Ali, A. and Mesfin, G. and Seboxa, T (2012) 'Veno-occlusive liver disease: a case report', Ethiopian Medical Journal, 50 Suppl 2, pp. 47-51. Available at: https://pubmed.ncbi.nlm.nih.gov/22946295/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22946295/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.